Sector ratings Shenyang Xingqi Pharmaceutical Co.,Ltd.

Equities

End-of-day quote Shenzhen S.E. Other stock markets 2024-09-11			5-day change	1st Jan Change
76.28 ^CNY	-0.69%		-5.32%	-41.43%

08-29	Shenyang Xingqi Pharmaceutical Co.,Ltd. Proposes Profit Distribution for First Half of 2024	CI
08-28	Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Composite Valuation	Composite Consensus	Composite Visibility	ESG Refinitiv	Capi. ($)
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	-	-	-	-	1.87B
MERCK KGAA				A	81.29B
KYOWA KIRIN CO. LTD.				A-	12.01B
YUHAN CORPORATION				B-	6.75B
SK BIOPHARMACEUTICALS CO., LTD.				A-	5.83B
BETTA PHARMACEUTICALS CO., LTD.				C-	2.36B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.		-	-	-	1.93B
SUPERNUS PHARMACEUTICALS, INC.	-			D+	1.71B
CHANGCHUN BCHT BIOTECHNOLOGY CO.				-	1.34B
INDIVIOR PLC				B	1.23B
KISSEI PHARMACEUTICAL CO., LTD.				-	1.08B
CALLIDITAS THERAPEUTICS AB				C	1.08B
OSCOTEC INC.	-			-	1.01B
HK INNO.N CORPORATION				-	935M
SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.	-		-	C	926M
Average				B-	8.09B
Weighted average by Cap.				B-